Skip to Content Skip to Main Navigation Skip to Local Navigation Skip to Search

betamethasone dipropionate - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
CALCIPOTRIOL/BETAMETHASONE SANDOZ 50/500 calcipotriol 50 microgram/g and betamethasone (as dipropionate) 500 microgram/g ointment tube
AUST R: 255532
Active ingredients:
betamethasone dipropionate
calcipotriol

Dosage form:
Ointment

Sponsor:
Sandoz Pty Ltd

Phone:
1800 726 369

From
03 Feb 2023
to
28 Apr 2023

Shortage status:
Resolved

Availability:
Available

Reason:
Manufacturing
DAIVOBET 50/500 calcipotriol 50 microgram/g and betamethasone (as dipropionate) 500 microgram/g gel bottle
AUST R: 161936
Active ingredients:
betamethasone dipropionate
calcipotriol

Dosage form:
Gel

Sponsor:
LEO Pharma Pty Ltd

Phone:
1800991778

Deletion from market:
30 Jun 2022

Shortage status:
Discontinued

Availability:
Unavailable

Reason:
Commercial Changes / Commercial viability

Management action:
Daivobet Gel will be replaced by ENSTILAR calcipotriol (as monohydrate) 50 microgram/g and betamethasone (as dipropionate) 500 microgram/g foam aerosol can - AUST R 263292